| Original language | English (US) |
|---|---|
| Pages (from-to) | 2987-2989 |
| Number of pages | 3 |
| Journal | Journal of the American Society of Nephrology |
| Volume | 32 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2021 |
Funding
P.M. Palevsky reports serving as president of the National Kidney Foundation, as a member of the Renal Physicians Association’s Quality, Safety and Accountability Committee, and as chair of the Quality Insights Renal Network 4 Medical Review Board; consultancy agreements with Jans-sen Research & Development, LLC; and serving as section editor for acute kidney injury for UpToDate and as a member of the editorial board of the Journal of Intensive Care Medicine. S.E. Quaggin reports serving as the president of the American Society of Nephrology and as chief scientific officer and founder of Mannin Research; having consultancy agreements with AstraZeneca, Genentech, Goldfinch, Janssen, Johnson & Johnson, the Lowy Medical Research Foundation, Novartis, Pfizer, and Roche; serving as a scientific advisor or member of AstraZeneca, Genentech/ Roche, JCI, Karolinska Cardiovascular, Renal and Metabolism Institute, Lowy Medical Research Institute, Mannin, Novartis, Pfizer, and the Pfizer Advancing Science through Pfizer-Investigator Research Exchange program committee; receiving research funding from AstraZeneca and Mannin Research; having ownership interest in Mannin Research; and receiving honoraria from the Japanese Society of Nephrology and Korea Advanced Institute of Science and Technology (for plenary lecture).
ASJC Scopus subject areas
- General Medicine
